Accession Number: | 0000921895-22-001802 |
Date: | 2022-05-24 |
Issuer: | HARVARD BIOSCIENCE INC (HBIO) |
Original Submission Date: |
EDRICK ALAN I
C/O HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL RD.
HOLLISTON, MA 01746
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-05-24 | A | 38,259 | a | $0.00 | 172,485 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents an award of 38,259 restricted stock units that fully vest on the earlier to occur of (i) the date of the issuer's next annual meeting of stockholders after may 17, 2022, immediately prior to the commencement of such meeting, and (ii) may 24, 2023. |
f2 | includes (a) the award described in footnote (1) above and (b) 134,226 shares of common stock held by the reporting person. |